Gastric Cancer Risk Factors Associated With EU and CELAC Populations

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-31

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study uses a case-control design that examines the differences in types of exposures between cases defined with a pathological confirmation of GC diagnosis, and controls, defined as patients to whom a gastroscopy was indicated and confirmed absent of GC i

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

NCT04019808

Gastric Cancer

COMPLETED

Volatile Markers in Digestive Cancer

NCT02332213

Colorectal Cancer Colorectal Adenoma Gastric Cancer +6 more

COMPLETED

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

NCT06370143

Gastric Atrophy Gastric Intestinal Metaplasia Dysplasia +2 more

RECRUITING

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

NCT05732623

Colorectal Cancer Early Onset Colorectal Cancer Diet Habit +1 more

RECRUITING

Establishment and Validation of a Clinical Predictive Model for Gastrointestinal Cancer Screening Based on Patient-related Risk Factors

NCT06118437

Malignant Tumor of Digestive Tract Risk Factors

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

GC is associated to several known risk factors. Epidemiological and molecular features of GCs can vary widely. The reasons behind these differences are multiple and complex and may include genetic susceptibility, strains of the bacterium Helicobacter pylori (H. pylori), Epstein Barr virus infection, dietary factors and others. These factors can influence GC outcomes. There is little knowledge regarding how these risk factors are associated with GC in CELAC and EU populations.

The primary objectives of this study are to:

1. Identify risk factors associated with GC in the CELAC and EU populations participating in this study including Argentina, Spain, Mexico, Netherlands, Chile, Portugal and Paraguay.
2. Identify clinical, demographic, and epidemiological differences among the populations participating in this study

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer, Gastric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases

Patients with a pathological confirmation of GC diagnosis

No interventions assigned to this group

Control

Patients with confirmed absent of GC

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects ≥18 years old.
* GC diagnosis (including gastroesophageal junction cancer) from IPATIMUP, INCAN, VUMC, PUC, VHIO, IAF, INCLIVA and GENPAT centres, in the last six months before his/her inclusion in the study.
* Has given and signed the IC to participate in this study.

* Subjects ≥18 years old.
* Subjects to whom a gastroscopy was indicated in its medical care and confirmed absent of GC in the same centres will be matched in age (+/- 10 years), gender and pertaining from the same region of the GC case. Thus, to match our GC cases same number of controls is expected to be recruited.
* Has given and signed the IC to participate in this study.

Exclusion Criteria

* Patients diagnosed with GC (including gastroesophageal junction cancer) from other centres/ countries not participating in this proposal.
* Patients with suspected with GC diagnosis but not confirmed by the pathological report.

Controls

* Subjects from a different geographic area from the cases.
* Patients with high suspicion of GC (including gastroesophageal junction cancer) or previous personal history known of document chronic gastritis diagnosed by endoscopy and confirmed by histology.

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes